Skip to main content
. 2020 Jul 14;9(7):e17160. doi: 10.2196/17160

Table 2.

Summary of smoking outcomes from the iQuit in Practice pilot trial.

Smoking outcomes for the iQuit in Practice pilot trial Control arm, n (%) Intervention arm, n (%) Absolute difference, % (95% CI) Odds ratio (95% CI)
Primary outcome

Self-reported 2-week point-prevalence abstinence at 8-week follow-up 122 (40.3) 135 (45.2) 4.9 (−3.0 to 12.7) 1.22 (0.88 to 1.69)
Secondary outcomes

Carbon monoxide–verified 2-week point-prevalence abstinence at 4-week follow-up after quit date 71 (23) 81 (27) 3.7 (−3.3 to 10.6) 1.21 (0.84 to 1.76)

Self-reported 3-month prolonged abstinence at 6-month follow-up 70 (23) 76 (25) 2.3 (−4.5 to 9.1) 1.13 (0.78 to 1.65)
Additional outcomes

Self-reported 6-month prolonged abstinence at 6-month follow-up 27 (9) 45 (15) 6.1 (0.9 to 11.4) 1.81 (1.09 to 3.01)

Continuous abstinence (4-week, 8-week, and 6-month follow-ups) 19 (6) 34 (11) 5.1 (0.6 to 9.8) 1.92 (1.07 to 3.45)